A Single Centre, Pilot Trial of YF476 in Patients With Chronic Atrophic Gastritis, Hypergastrinaemia and Type I Gastric Carcinoids.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 21 Oct 2016
At a glance
- Drugs Netazepide (Primary)
- Indications Gastric atrophy; Gastric cancer
- Focus Therapeutic Use
- Sponsors Trio Medicines
- 07 Jun 2017 Biomarkers information updated
- 17 Oct 2016 Planned End Date changed from 1 Jul 2016 to 1 Jul 2017.
- 17 Oct 2016 Planned primary completion date changed from 1 Jul 2016 to 1 Jul 2017.